Navigation Links
AcelRx Pharmaceuticals to Present at Canaccord Genuity 33rd Annual Growth Conference
Date:8/5/2013

REDWOOD CITY, Calif., Aug. 5, 2013 /PRNewswire/ -- AcelRx Pharmaceuticals, Inc. (Nasdaq: ACRX), a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain, today announced that Richard King, President and CEO, will present a corporate overview at the Canaccord Genuity 33rd Annual Growth Conference at the Intercontinental Boston, Boston, MA.  The presentation is scheduled for Thursday, August 15, 2013 at 2:30 p.m. ET/11:30 a.m. PT.

The presentation will be webcast live and can be accessed through the Investors page at www.acelrx.com.  For those not available to listen to the live broadcast, a replay of the presentations will be archived for 90 days and available through the Investors page on www.acelrx.com.

About AcelRx Pharmaceuticals, Inc.

AcelRx Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of acute and breakthrough pain.  AcelRx's lead product candidate, Zalviso, is designed to solve the problems associated with post-operative intravenous patient-controlled analgesia which has been shown to cause harm to patients following surgery because of the side effects of morphine, the invasive IV route of delivery and the complexity of infusion pumps.  AcelRx has announced positive results from each of the three Phase 3 clinical trials for Zalviso and AcelRx anticipates submitting a New Drug Application with the FDA in the third quarter of 2013. AcelRx also announced positive top-line results for a Phase 2 trial for ARX-04, a sufentanil formulation for the treatment of moderat
'/>"/>

SOURCE AcelRx Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AcelRx Pharmaceuticals Reports First Quarter 2012 Financial Results
2. AcelRx Pharmaceuticals Announces Pricing of a $10.0 Million PIPE Financing
3. AcelRx Pharmaceuticals, Inc. to Webcast, Live, at RetailInvestorConferences.com on July 12th
4. AcelRx Pharmaceuticals, Inc. Investor Presentation Now Available for On-demand Viewing at RetailInvestorConferences.com
5. AcelRx Pharmaceuticals Receives Two Additional U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
6. AcelRx Pharmaceuticals to Hold Second Quarter 2012 Financial Results Conference Call and Webcast on August 9, 2012
7. AcelRx Pharmaceuticals to Present at the Canaccord Genuity 32nd Annual Healthcare Conference
8. AcelRx Pharmaceuticals Reports Second Quarter 2012 Financial Results
9. AcelRx Pharmaceuticals to Present at Three Upcoming Investor Conferences
10. AcelRx Pharmaceuticals Receives Fourth and Fifth U.S. Patents for Small-Volume Oral Transmucosal Dosage Forms
11. AcelRx Pharmaceuticals to Present at the UBS Global Life Sciences Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2015)... 2015 The preclinical contract research organization Absorption ... and safety testing of medical devices, announces that its Chief ... workshop " Drug Transporters in ADME: From the Bench to ... The title of Dr. Hidalgo,s talk is "Modern Tools for ... "Transporter Tools of the Future." The workshop, organized ...
(Date:4/20/2015)... Ingenuity Health, a leading provider of monitoring solutions to ... National Council of Behavioral Health annual conference in ... percent of the samples collected from patients with serious ... medication. ... Medication nonadherence can result ...
(Date:4/20/2015)... LINCOLNSHIRE, Ill. , April 20, 2015  U.S. pharmacy ... are expected to drift into the low double-digits by 2016, ... global talent, retirement and health solutions business of Aon ... plan design changes are projected to be 9.5 percent in ... 2016. Aon Hewitt predicts a similar rate of ...
Breaking Medicine Technology:Absorption Systems Chief Scientist Ismael Hidalgo to Present at International Workshop on Drug Transporters 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 2Ingenuity Health Research Flags Potentially High Rate of Medication Nonadherence Among Those with Serious Mental Illness 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 2Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 3Aon Analysis Shows Double-Digit Increases in U.S. Pharmacy Costs by 2016 4
... 26, 2011 Hamilton Company has been awarded a ... announced today. Hamilton Company, the Reno, NV-based global leader in ... investment in the manufacturing facility of its Swiss subsidiary Hamilton ... Named after Swiss national hero Wilhelm Tell, the Awards are ...
... 2011 Pinktimeline.com launched as a resource for the ... of First Response, and Zita West, fertility expert and midwife to ... for a baby. First Response has announced the launch of a ... trying for a baby, especially during the ,2-week wait., ...
Cached Medicine Technology:Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 2Hamilton Company Wins Switzerland's 2010 Tell Award for Manufacturing Investment in Grisons, Greater Zurich Area 3First Response Partners With Fertility Expert Zita West to Support Those Trying for a Baby 2
(Date:4/20/2015)... (PRWEB) April 20, 2015 Genuine fat loss ... diets and gym memberships in the past. But what failed ... results can be guaranteed by adhering to five simple ... diet. No matter how many hours one spends working at ... to lose weight., But a nutritional mean plan does not ...
(Date:4/20/2015)... Burlington, Vt. (PRWEB) April 20, 2015 ... environmental networks, is excited to announce that Kate Williams, the ... CEO, effective May 1, 2015. , Williams has been part ... nearly decade-long tenure as Executive Director of the Northern Forest ... Williams has dedicated her career to the stewardship of and ...
(Date:4/20/2015)... (PRWEB) April 20, 2015 Today ... Cancer-Ovarian Cancer Research Fund-Ovarian Cancer National Alliance-National Ovarian ... The Dream Team will focus on “DNA Repair ... that have identified DNA repair as a common ... the prevention and early detection of ovarian cancer ...
(Date:4/20/2015)... April 20, 2015 Grateful Dead ... united as one until 1995. The group was more than ... reggae, rock, bluegrass, folk, space rock, country, and other genres ... the ultimate jam band. The group was inducted into the ... total has sold more than 35 million records worldwide. ...
(Date:4/20/2015)... April 20, 2015 Northern Westchester ... & Medicaid Services introduced their new 5-star “Patient Experience” ... Assessment of Healthcare Providers and Systems) survey of hospital ... about their experiences during a recent hospital stay. ... 1, 2013 through June 30, 2014 can be reviewed ...
Breaking Medicine News(10 mins):Health News:Guarantee Fat Loss Results With 5 Easy Tips 2Health News:Guarantee Fat Loss Results With 5 Easy Tips 3Health News:1% for the Planet Announces New CEO 2Health News:1% for the Planet Announces New CEO 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 2Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 3Health News:New Ovarian Cancer Dream Team to Research DNA Repair Therapies 4Health News:Grateful Dead Tickets at Levi’s Stadium in Santa Clara: Ticket Down Slashes Grateful Dead Tickets in Santa Clara @ Levi’s Stadium for "Fare Thee Well" 50th Anniversary 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 2Health News:Northern Westchester Hospital Named a 5-Star Hospital In Medicare's Patient Satisfaction Rating 3
... A study led by researchers in the Department of Neurosciences ... shows unexpected and extensive natural recovery after spinal cord injury ... the advance online edition of Nature Neuroscience , may ... patients with spinal cord injuries. While regeneration after ...
... the past three decades in at least one metropolitan ... the habit, according to research presented at the American ... a population-based, serial cross-sectional study of trends in cardiovascular ... each of its six surveys. Examining the smoking ...
... Diego - A brain scan with functional MRI (fMRI) is ... respond to "talk therapy," and so may not need to ... Their study, being presented at the annual meeting of ... and adolescents, ages 8 to16, who show fear when looking ...
... Americans require dialysis to treat kidney disease; of that ... caused by cardiovascular disease. Dialysis patients are at ... unclear why these deaths occur because little research has ... disease in this high-risk population. Northwestern ...
... SUNDAY, Nov. 14 (HealthDay News) -- New research suggests that ... black patients, even though it appears to double the risk ... findings, given that prior research has revealed that blacks are ... to experience a stroke, compared with white patients. Blacks also ...
... 14 (HealthDay News) -- In the months following the death of ... face a higher risk of heart attack or sudden cardiac death ... risk tends to dissipate within six months, the study authors said. ... directed toward the deceased person, the health and welfare of bereaved ...
Cached Medicine News:Health News:Research uncovers extensive natural recovery after spinal cord injury 2Health News:Smoking among some adults dropped dramatically in past three decades 2Health News:Smoking among some adults dropped dramatically in past three decades 3Health News:Smoking among some adults dropped dramatically in past three decades 4Health News:Smoking among some adults dropped dramatically in past three decades 5Health News:Smoking among some adults dropped dramatically in past three decades 6Health News:GUMC: fMRI predicts outcome to talk therapy in children with an anxiety disorder 2Health News:Patients receiving dialysis are at a heightened risk for sudden cardiac death 2Health News:Patients receiving dialysis are at a heightened risk for sudden cardiac death 3Health News:Vitamin D Shortage Not Tied to Stroke Deaths in Blacks: Study 2Health News:Death of Loved One May Trigger Elevated Heart Rate 2
Steerable catheter that is ideal for mapping unusual anatomy...
... The LASSO Circular Mapping Catheter from Biosense ... of circumferentially mapping the myocardial sleeves around ... allows the sequential assessment of PV potentials ... isolation. The circular LASSO curve with ...
Standard Deflectable Catheters...
... The reliable, easy-to-steer Bart EPXT ... shaft stability and curve control for ... point-of-tip actuation control supplies exceptional levels ... extraordinary family of small, medium and ...
Medicine Products: